Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03879811
Title Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

colorectal cancer

Therapies

Nivolumab

Temozolomide

Age Groups: adult | senior
Covered Countries


No variant requirements are available.